Basf Se Corporation

Bayer Intellectual Property Gmbh

Basf Agro B.v.

Other

Bayer Pharma Aktiengesellschaft

Bayer Schering Pharma Ag

Frederik Menges

Michael Rack

Michael Keil

Joachim Gebhardt

Rolf Bohlmann

Joachim Kuhnke

Steffen Borden

Katja Prelle

Ulrich Klar

Thomas Frenzel

Sven Ring

Hans-Peter Muhn

David Cortes

Helmut Zech

Rodney F Klima

Robert Leicht

Jan Hübner

Uwe Josef Vogelbacher

Jan Klaas Lohmann

Martin Semar

Jochen Schroeder

Bernd Wolf

Egon Haden

Maximilian Dochnahl

Nadege Boudet

Lutz Brahm

Jens Renner

Dieter Strobel

Siegfried Strathmann

Wassilios Grammenos

Bernd Mueller

Volker Maywald

Bernd Müller

Sebastian Soergel

Jochen Schröder

Jan Huebner

Murat Mertoglu

Winfried Mayer

Thorsten Jabs

Stefan Orsten

Nadine Riediger

Ronald Wilhelm

Annette Schuster

Kristin Klappach

Florent Mazuir

Hans Peter Muhn

Norbert Gallus

Jens Bruns

Tony Yegerlehner

Marianna Vrettou-Schultes

The present invention relates to compositions comprising, 1) as component I a compound of formula I, as defined in the claims and description, and 2) as component II an active ingredient, selected from the groups A) to O) defined in the claims and description.

Compositions comprising a triazole compound

Compositions comprising a triazole compound and a biopesticide.

Compositions comprising a triazole compound and a biopesticide

The present invention relates to compositions comprising a triazole compound as component I and as a component II a compound selected from (II-1) to (II-8) and to the agrochemical compositions and the uses thereof.

Pesticidal compositions

The present invention relates to pesticidal compositions comprising as component I a compound selected from the compounds I-1 to I-31 and as component II a compound selected from compounds II-1 to II-12.

A process for manufacturing 5-chloromethyl-2,3-pyridine dicarboxylic acid anhydrides (I)   Compounds (I) are useful intermediates in the synthesis of herbicidal imidazolinones.

Process for manufacturing 5-chloromethyl-2,3-pyridine dicarboxylic acid anhydrides

The present invention relates to a process using Grignard reagents for providing thio-triazolo group-containing compounds.

Process using Grignard reagents

A process for manufacturing 5,6-disubstituted-3-pyridylmethyl ammonium bromides (I), wherein wherein the symbols have the meaning given in formula (I), with bromine in the presence of a radical initiator in a solvent mixture comprising an aqueous phase and an organic phase, where the organic phase comprises a solvent selected from 1,2-dichloroethane, chlorobenzene, 1,2-dichlorobenzene, 1,3-dichlorobenzene, 1,4-dichlorobenzene and tetrachloromethane, and where the pH-value of the aqueous phase is from 3 to &#x3c;8, to obtain a 3-bromomethyl-5,6-disubstituted pyridine compound (III), wherein Y, Y, Z and Zhave the meanings given in formula (I), and

Process for manufacturing substituted 3-pyridylmethyl ammonium bromides

The invention relates to 17-(1'-propenyl)-17-3&#x2032;-oxidoestra-4-en-3-one derivatives with the general chemical formula I, where the residues Z, R, R, R, R, R, R, Rand Rhave the meanings stated in Claim, and their solvates, hydrates and salts, including all stereoisomers of these compounds. The invention further relates to the use of these derivatives for the production of a medicinal product for oral contraception and for the treatment of pre-, peri- and postmenopausal complaints and medicinal products that contain said derivatives, and in particular application in the aforementioned indications. The derivatives according to the invention have a progestational and in preferred cases additionally an antimineralocorticoid and neutral to slightly androgenic action. 

17-(1'propenyl)-17-3&#x2032;-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative

The 15&#x3b1;,16&#x3b1;-methylene-17-hydroxy-19-nor-17-pregna-4-en-3-one-21-carboxylic acid &#x3b3;-lactone derivatives of the present invention possess progestational efficacy. They have the general chemical formula I, in which Z is selected from the group comprising an oxygen atom, two hydrogen atoms, NOR and NNHSOR, where R is hydrogen, C-C-alkyl, aryl or C-C-aralkyl, Ris hydrogen or halogen, and moreover either: R, Rtogether form methylene or 1,2-ethanediyl or Ris hydrogen and Ris selected from the group comprising hydrogen, C-C-alkyl, C-C-alkenyl or C-C-alkynyl, and Ris selected from the group comprising hydrogen, C-C-alkyl, C-C-cycloalkyl, C-C-alkenyl or C-C-alkynyl, or: Ris hydrogen and Rand R, together, denote a bond, an oxygen or form methylene, Rrepresents hydrogen or C-C-alkyl and in addition include their solvates, hydrates, stereoisomers and salts. 

19-nor-steroid derivatives with a 15&#x3b1;,16&#x3b1;-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives

The invention relates to 17-hydroxy-19-nor-21-carboxylic acid-steroid &#x3b3;-lactone derivatives with the chemical formula I, where R, R, R, R, R, R, R, Rand Z have the meanings stated in claim, and their solvates, hydrates, stereoisomers and salts. The invention further relates to the use of these derivatives for the production of a medicinal product for oral contraception and for the treatment of pre-, peri- and postmenopausal complaints and medicinal products that contain said derivatives. The derivatives according to the invention have a progestational and in preferred cases additionally an antimineralocorticoid and neutral to slightly androgenic action. 

17-hydroxy-19-nor-21-carboxylic acid-steroid &#x3b3;-lactone derivative, use thereof, and medicament containing the derivative

Process using grignard reagents

The present invention relates to a process for preparing 4-hydroxypyridines of formula I wherein R, R, Rand Rhave the meanings defined in the description.

Process for preparing 4-hydroxypyridines

A process for manufacturing a 5-formyl-pyridine-2,3-dicarboxylic acid ester (I) wherein Z is hydrogen or halogen; Zis hydrogen, halogen, cyano or nitro and R, Rare independently C-C-alkyl, comprising the steps of (i) reacting a compound of formula (II), wherein the symbols are as in formula (I), with a nitrosation agent (III) R&#x2014;O&#x2014;N&#x2550;O (III) wherein Ris C-C-alkyl, in the presence of an alkali metal or alkaline earth metal alcoholates or carbonates in a polar aprotic solvent at a temperature of from &#x2212;45 to 40&#xb0; C., to obtain an oxime compound (IV) where Z, Z, Rand Rare as in formula (I), and (ii) reacting oxime compound (IV) with an aliphatic C-C-aldehyde in the presence of a Lewis acid at a temperature in the range of from 0 to 100&#xb0; C. The compounds of formula (I) are useful intermediates in the synthesis of herbicidal imidazolinones, like imazamox. 

Process for manufacturing 5-formyl-pyridine-2,3-dicarboxylic acid esters

The invention relates to 15,16-methylene-17-(1'-propenyl)-17-3&#x2032;-oxidoestra-4-en-3-one derivatives with the general chemical formula I, where the Z, R, R, R, Rand Rhave the meanings stated in claim, and solvates, hydrates and salts thereof, including all crystal modifications and all stereoisomers of these compounds. The invention also relates to the use of these derivatives for the production of a drug for oral contraception and for the treatment of pre-, peri- and postmenopausal problems and drugs which contain such derivatives, in particular use in the aforesaid indications. The derivatives according to the invention have a progestational and in preferable cases also an antimineralcorticoid and neutral to slight androgenic activity. 

15, 16-methylene-17-(1'-propenyl)-17,3&#x2032;-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative

Growing community of inventors

Schriesheim, Germany

Frederik Menges